Prospective Study Of The Relationship Between Clinical Outcomes Of Enzalutamide And Serum Androgen Levels Measured By Lc-Ms/Ms In Crpc Patients

Yoshiyuki Miyazawa,Takeshi Miyao,Toshiyuki Nakamura,Yutaka Takezawa,Nobuaki Shimizu,Yasushige Matsuo,Haruyuki Ogura,Tomoyuki Takei,Yoshitaka Sekine,Seiji Arai,Kazuhiro Suzuki

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览45

暂无评分

摘要

146Background: Enzalutamide (ENZ) is commonly used to treat patients with castration resistant prostate cancer (CRPC). However, the kinetics of serum androgen levels before and after ENZ treatment ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要